PC5514 - Pharmaceutical Public Health - Management of Chronic Diseases 2

Credit points:	03
Year:	2014
Student Contribution Band:	Band 2
Administered by:

Pharmaceutical Public Health is a developing specialty which seeks to influence pharmaceutical health determinants on a population basis, rather than having a focus on the individual patient. However, in the implementation of pharmaceutical public health services it is still important for pharmacists to possess a current knowledge of the clinical management of key disease states. This is one of a series of subjects that review both the clinical management and the pharmaceutical public health issues associated with a range of key disease states. This subject focusses mainly on two health problems that are currently prevalent in the developed world and are becoming increasingly prevalent in the developing world: Cardiovascular Disease and Diabetes. The subject introduces the student to the pharmaceutical public health issues associated with these diseases and some clinical management issues, as well as public health issues related to tobacco smoking and obesity.

Learning Outcomes

• demonstrate a mastery and understanding of a body of theoretical knowledge relating to a number of pharmacuetical public health priority areas including principally; Cardiovascular disease and diabetes;
• demonstrate an ability to critically analyse and/or adapt, construct and develop strategies and guidelines to promote and optimise the provision of ethically and culturally appropriate pharmaceutical public health services in a number of pharmaceutical public health priority areas including principally; cardiovascular disease and diabetes;
• demonstrate an ability to critically analyse, review, evaluate and develop strategies for the enhancement of the role of pharmacists and pharmacies in the provision of services in a number of pharmaceutical public health priority areas including principally; cardiovascular disease and diabetes;
• demonstrate an ability to interpret and accurately and appropriately communicate and disseminate a broad range of theoretical and actual pharmacuetical public health concepts, chiefly in the areas of cardiovascular disease and diabetes to both specialist and non- specialist audiences.

Availabilities
External, Study Period 1
Census Date 27-Mar-2014
Coordinator:	Assoc. Professor Ian Heslop
Lecturer:	Mr Aaron Drovandi.
Method of Delivery:	WWW - LearnJCU and Printed materials
Assessment:	end of semester exam (40%); assignments (60%).

Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.